|Mr. Robert Abenante||Pres, CEO & Director||N/A||N/A||N/A|
|Mr. Douglas J. Sorocco LLB||Advisor||N/A||N/A||1971|
|Mr. Guy P. Dancosse||Advisor||N/A||N/A||1944|
|Mr. Francesco Paolini||CFO & Director||N/A||N/A||N/A|
|Mr. Patrick Mitchell||Chief Operating Officer||N/A||N/A||N/A|
Abattis Bioceuticals Corp., a biotechnology company, researches, develops, licenses, and markets ingredients and formulas for use in the biopharma, nutraceutical, cosmetic, and animal nutrition markets in Canada. It is also involved in the possession of cannabis and related active ingredients, as well as the production of extracts; and marketing services. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Abattis Bioceuticals Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.